Vimentin in cancer and its potential as a molecular target for cancer therapy. - Wikidata - awgldk - TriplyDB

Vimentin in cancer and its potential as a molecular target for cancer therapy.

Vimentin in cancer and its potential as a molecular target for cancer therapy.

http://www.wikidata.org/entity/Q35182104

about

Long-term effects of carbon containing engineered nanomaterials and asbestos in the lung: one year postexposure comparisons Targeting MCT-1 oncogene inhibits Shc pathway and xenograft tumorigenicity Vimentin, colon cancer progression and resistance to butyrate and other HDACis Epithelial to Mesenchymal Transition in a Clinical Perspective Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention Intermediate Filaments Play a Pivotal Role in Regulating Cell Architecture and Function CARMIL2 is a novel molecular connection between vimentin and actin essential for cell migration and invadopodia formation Networking galore: intermediate filaments and cell migration Significance of circulating tumor cells in soft tissue sarcoma.The Indispensable Roles of Microglia and Astrocytes during Brain Development Dynamic self-guiding analysis of Alzheimer's disease.Cell Migration and Invadopodia Formation Require a Membrane-binding Domain of CARMIL2.BRCA1-associated protein 1 deficiency in lung adenocarcinoma predicts poor outcome and increased tumor invasion Immune-associated proteins with potential inï¿½vivo anti-tumor activities are upregulated in lung cancer cells treated with umbelliprenin: A proteomic approach Withaferin a alters intermediate filament organization, cell shape and behavior Extract of Pleurotus pulmonarius suppresses liver cancer development and progression through inhibition of VEGF-induced PI3K/AKT signaling pathway Krüppel-like factor 4 acts as an oncogene in colon cancer stem cell-enriched spheroid cells Inhibition of histone deacetylase impacts cancer stem cells and induces epithelial-mesenchyme transition of head and neck cancer Variable metastatic potentials correlate with differential plectin and vimentin expression in syngeneic androgen independent prostate cancer cells Tumor cell heterogeneity in Small Cell Lung Cancer (SCLC): phenotypical and functional differences associated with Epithelial-Mesenchymal Transition (EMT) and DNA methylation changes Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells A Hybrid Chalcone Combining the Trimethoxyphenyl and Isatinyl Groups Targets Multiple Oncogenic Proteins and Pathways in Hepatocellular Carcinoma Cells Methods for Determining the Cellular Functions of Vimentin Intermediate Filaments SORBS1 suppresses tumor metastasis and improves the sensitivity of cancer to chemotherapy drug DNA-aptamer targeting vimentin for tumor therapy in vivo.Effect of the leptin receptor Q223R polymorphism on the host transcriptome following infection with Entamoeba histolytica.Platelet adhesion involves a novel interaction between vimentin and von Willebrand factor under high shear stress Microtubule-dependent transport of vimentin filament precursors is regulated by actin and by the concerted action of Rho- and p21-activated kinases Zebrafish reporter lines reveal in vivo signaling pathway activities involved in pancreatic cancer.Microtubule-dependent transport and dynamics of vimentin intermediate filaments Real-time analysis of epithelial-mesenchymal transition using fluorescent single-domain antibodies The CO-Regulation Database (CORD): a tool to identify coordinately expressed genes Impact of an altered PROX1 expression on clinicopathology, prognosis and progression in renal cell carcinoma.CPEB1 promotes differentiation and suppresses EMT in mammary epithelial cells Comparative Proteomic Analysis of Tumor Mesenchymal-Like Stem Cells Derived from High Grade versus Low Grade Gliomas Circulating proteolytic signatures of chemotherapy-induced cell death in humans discovered by N-terminal labeling.Vimentin is a potential prognostic factor for tongue squamous cell carcinoma among five epithelial-mesenchymal transition-related proteins.Androgen receptor as a driver of therapeutic resistance in advanced prostate cancer.Higher serum concentrations of vimentin and DAKP1 are associated with aggressive breast tumour phenotypes in Ghanaian women Anaplastic astrocytoma mimicking progressive multifocal leucoencephalopathy: a case report and review of the overlapping syndromes

P2860

Q23909987-1AD53317-19FB-4582-9CDB-F978C9C54E52 Q24596766-D555C04D-7FCF-491E-904C-77AD89208F35 Q26748816-9AB41F63-B93E-4F5F-A26A-D77266F91AA7 Q26783554-6E2AB9F6-F5C4-4BCF-B913-6F9BBFC88485 Q26864839-20ED2CCF-E0DE-4B46-844D-A0BF45A184E5 Q26865818-CF9D9687-E4EE-4535-829E-D5D9FF7601EA Q27305215-439E5297-FF80-40BB-9766-C5A24AA5E347 Q27693294-E7470DB7-A779-4223-AE86-90EBE0FFFE63 Q27693309-B66B85D8-8A6C-4CF1-97C1-77DE87CAD155 Q28067530-1888F6A1-00B1-4160-A242-C8CCDB55378B Q28080897-378840B4-C339-4920-A66A-7C88113D87A1 Q28116157-F67CB4B5-3DB5-41B0-87B6-C23464EF11CF Q28387249-330E8992-1F15-43C7-870E-C28D34E7D809 Q28468345-3A052769-F7FA-464F-96E4-0CEEC4465483 Q28480441-06F92E7A-8F0E-4310-8E65-C4050B34B44A Q28481696-A40FAD29-2456-422E-9C26-BC1B325F4664 Q28486138-3BC61BCD-2B3B-4FF7-80A6-AA924510D0AC Q28488474-B933B53A-5FB3-47C6-8697-EEE0A88A6CCA Q28533234-4DD8B779-BAAE-4341-9DD8-DDB3515A4DD1 Q28539958-2BF331FA-E8B3-4B9A-A796-A2B58C8329E8 Q28546641-70E89E2C-8D46-4EF9-A8B1-B459C373D0EC Q28553513-5BCC4076-F761-4415-870A-E4C55C5560A6 Q28833746-FAA28B5B-1983-46B7-8C03-049DEA582CD4 Q30008832-E28F00EA-C626-48BB-B977-7F49DED4D100 Q30415521-5D16A9EA-BB40-49FC-A294-C138BCEF0E46 Q30416574-C58E4280-2DAC-4F7B-BD15-A02EA58BD2FA Q30577008-D1FB22EA-F076-4BEA-A295-B786E71886E0 Q30581023-4460A23F-C248-4394-AAA7-7FFEB7FAB414 Q30581795-202FE7B1-C539-422A-A4DF-8DA6ABADFAEC Q30651023-DB24254D-1FF4-4652-B6C9-214A0AD46F73 Q30661925-00C50292-B5A8-4632-A260-49759BED9CA6 Q31152739-B6A2E6C2-C944-4386-888E-5EF839D3A3B0 Q33567647-9B9CCCFA-7F2E-4FAF-981F-DCB005044A31 Q33613379-303107C7-408C-4970-B537-D3D6C6A545B6 Q33625804-8978FF53-9E35-425B-838F-80A0FFE204A3 Q33694691-242DD8B0-373A-4E73-8F0D-7F48F09D6EF2 Q33751870-8DBB492B-1F89-4DDF-8E43-9BC269F4F899 Q33775723-F3617E85-A63D-4F8A-9733-559EB9E4D008 Q33785036-59659ADB-E627-4905-8DF9-9D5586990976 Q33814485-ED2811C5-E2E9-4B46-80DE-9C6C33A58332

P2860

Vimentin in cancer and its potential as a molecular target for cancer therapy.

http://www.wikidata.org/entity/Q35182104

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Vimentin in cancer and its potential as a molecular target for cancer therapy.

@ast

Vimentin in cancer and its potential as a molecular target for cancer therapy.

@en

type

label

Vimentin in cancer and its potential as a molecular target for cancer therapy.

@ast

Vimentin in cancer and its potential as a molecular target for cancer therapy.

@en

prefLabel

Vimentin in cancer and its potential as a molecular target for cancer therapy.

@ast

Vimentin in cancer and its potential as a molecular target for cancer therapy.

@en

P1433

Q35182104-D76116BC-CF90-4383-823C-2BA176B65455

P1476

Q35182104-C8609938-9E3C-4DF4-9255-FE1760B5848F

P2093

Q35182104-9632D185-077C-48D9-BEC8-D4983BE0211B

Q35182104-EA6E5B52-97F9-4C79-BD7D-825380E2992C

P2860

Q35182104-02113574-639D-4418-BBBB-9281CDBA9D24

Q35182104-0291D4DE-767D-4C62-8A2F-E48A2BC31052

Q35182104-0406C07C-8D90-4BBC-B171-7570CFD0841D

Q35182104-0594544D-5EC4-43ED-91FE-2DE06FFE9303

Q35182104-096B359F-A6DA-4510-AD19-80C70B3E314F

Q35182104-0BFD551B-ACE7-477C-9918-BB3DDC7F77D4

Q35182104-12C9941E-49E8-4196-ACA8-FF4C35795820

Q35182104-1A3339D2-F510-4C2A-A840-F8238CA866EE

Q35182104-1D66AE74-B3E1-46A6-BE9F-135C72C723FE

Q35182104-1E4EA524-9E11-4C55-9A40-3CB6BBC6F5DF

P2888

Q35182104-2F79C0BA-A139-4C52-A14D-BF9FB227AAAF

P304

Q35182104-612CCD93-B9CF-4C5B-B2DA-5BAE8AE90A70

P31

Q35182104-F4FAA4EE-583F-45D1-A6DC-2177F72F2AC4

P356

Q35182104-E0C2F460-CB44-4EA7-AA09-11C759239754

P433

Q35182104-77C815E1-2BFF-40E3-872F-DBD4FF9442D5

P478

Q35182104-F0235106-0E0A-4E7A-A31F-14858A679936

P577

Q35182104-D5DC9087-F6B0-46A2-B20C-A0F28E1BAFC1

P5875

Q35182104-8E75694B-E007-440B-A99C-B0A5AB1ACC50

P698

Q35182104-4175A4BA-D8B9-4537-8E8C-B9B3FD202D46

P932

Q35182104-D7452F0B-4081-4B1A-A732-3049977C7EF7

P356

S00018-011-0735-1

P1433

Cellular and Molecular Life Sciences

P1476

Vimentin in cancer and its potential as a molecular target for cancer therapy.

@en

P2093

Arun Satelli

http://www.w3.org/2001/XMLSchema#string

Shulin Li

http://www.w3.org/2001/XMLSchema#string

P2860

Citrullination: a small change for a protein with great consequences for rheumatoid arthritis

Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA*008 that is shed by tumor cells in exosomes

Vimentin is a novel AKT1 target mediating motility and invasion

ZBP-89 represses vimentin gene transcription by interacting with the transcriptional activator, Sp1

The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin

Epithelial-mesenchymal transitions in tumour progression

Calyculin A-induced vimentin phosphorylation sequesters 14-3-3 and displaces other 14-3-3 partners in vivo

Genes for intermediate filament proteins and the draft sequence of the human genome: novel keratin genes and a surprisingly high number of pseudogenes related to keratin genes 8 and 18

Phosphorylation and reorganization of vimentin by p21-activated kinase (PAK)

Aurora-B regulates the cleavage furrow-specific vimentin phosphorylation in the cytokinetic process

P2888

s00018-011-0735-1

P304

3033-3046

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00018-011-0735-1

http://www.w3.org/2001/XMLSchema#string

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51188335

http://www.w3.org/2001/XMLSchema#string

P698

21637948

http://www.w3.org/2001/XMLSchema#string

P932

3162105

http://www.w3.org/2001/XMLSchema#string